Uterus Transplants are Reinforcing Patriarchal Notions of ‘Biological Motherhood’
By Sneha Banerjee & Sarojini Nadimpally,
The Wire [India]
| 05. 20. 2017
Uterus transplants raise several ethical concerns drawing from the health risk posed to women, especially since the surgery is not meant to treat a life threatening condition.
Recent news on uterus transplant in India takes the infertility industry to a new level. The overarching rationale behind uterus transplant is that infertile women can ‘benefit’ from this and bear their own biological children.
The first such scientifically reported successful transplant was conducted in Sweden in 2013 where a 36-year-old, who was born without a uterus, received a donated womb from her mother. She gave birth to a baby boy using a transplanted womb in 2014. According to recent media reports, a private fertility clinic in Bengaluru has received permission from the Indian Council for Medical Research (ICMR) for uterus transplants for two women and the procedure will be undertaken as a research project. The minimum experience necessary for a clinical team to carry out this procedure, as per the Human Organ Transplant Act, is not available in India and hence the involvement of Swedish doctors, who pioneered the procedure, is being...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...